As of January 22, 2025, Celularity (CELU) has a market cap of $52.163 million USD. According to our data, Celularity is ranked No.8128 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $52.16 M |
11.54%
|
Dec 31, 2024 | $46.77 M |
-15.79%
|
Dec 29, 2023 | $55.54 M |
-80.85%
|
Dec 30, 2022 | $0.29 B |
-74.80%
|
Dec 31, 2021 | $1.15 B |
-53.45%
|
Dec 31, 2020 | $2.47 B |
10.55%
|
Dec 31, 2019 | $2.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Mesoblast
MESO
|
$2.03 B |
0.000 M
|
Australia
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Market Cap | = | CELU Stock Price | * | CELU Shares Outstanding |
= | $2.32 | * | 22.48 M | |
= | $52.16 M |